VascVersa Ltd

ReproGo

This regenerative medicine company develops stem cell-derived vascular cells and organoids for drug screening and treating chronic wounds and cardiovascular diseases.

VASCULAR THERAPIES

This biotechnology company develops biodegradable collagen implants delivering sirolimus to improve vascular access outcomes for patients with kidney and vascular disease.

Viacyte

This regenerative medicine company develops stem cell-derived islet replacement therapies for patients living with type 1 diabetes.

Neuvasq

This company develops Wnt surrogate antibodies to restore blood-brain and blood-retina barriers for patients with vascular retinopathies and neurological disorders.

CIRC Biosciences

This cell therapy company develops chemically induced retinal cells to restore vision for patients with macular degeneration and retinitis pigmentosa.

Versono

This company develops ultrasonic intravascular devices to treat complex arterial blockages for patients suffering from peripheral vascular disease and critical limb ischaemia.

Eyexora

This company develops therapeutics and medical devices for ophthalmic diseases to treat patients with vision-threatening conditions.

Aegle Therapeutics

This company develops extracellular vesicle therapies derived from stem cells to treat patients with rare dermatological disorders and severe burns.